ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 177,90
-0,02%
Dow Jones
44 722,06
0,00%
DAX
19 461,83
0,20%
Brent Oil
72,95
0,38%
Bitcoin
97 204,01
1,62%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) Actualités

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:PVCT
DateHeureSourceTitreSymboleSociété
25/11/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/11/202414h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/11/202421h34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/08/202401h23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/07/202422h07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/06/202412h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202416h54Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/05/202419h56Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/06/202315h46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/06/202300h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202321h19Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202320h42Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202322h53Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/05/202319h59Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/202320h43Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/03/202315h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/12/202214h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/10/202219h30Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/03/202222h05Edgar (US Regulatory)Annual Report (10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
25/11/202019h09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/201922h50Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201721h11Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201719h58Edgar (US Regulatory)(25-NSE)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/04/201723h17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/04/201723h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/03/201712h05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/03/201721h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/03/201712h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
31/01/201712h23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/01/201712h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
EU
ACA
Credit Agricole
NASDAQ
AMZN
Amazon.com
EU
MC
Lvmh Moet Hennessy Louis...
EU
EN
Bouygues
NASDAQ
NVDA
NVIDIA
EU
HO
Thales
COIN
AVAXUSD
Avalanche
EU
BN
Danone
EU
LR
Legrand
COIN
BTCUSD
Bitcoin
EU
VIV
Vivendi
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct